Betta Pharmaceuticals Revenue

Betta Pharmaceuticals had revenue of 843.88M CNY in the quarter ending September 30, 2024, with 15.65% growth. This brings the company's revenue in the last twelve months to 2.76B, down -0.01% year-over-year. In the year 2023, Betta Pharmaceuticals had annual revenue of 2.46B with 3.35% growth.

Revenue (ttm)

2.76B

Revenue Growth

-0.01%

P/S Ratio

8.35

Revenue / Employee

1.41M

Employees

1,961

Market Cap

22.95B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	2.46B	79.57M	3.35%
Dec 31, 2022	2.38B	130.77M	5.82%
Jan 1, 2022	2.25B	375.59M	20.08%
Dec 31, 2020	1.87B	316.34M	20.36%
Dec 31, 2019	1.55B	329.75M	26.94%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	27.98B
Shenzhen Mindray Bio-Medical Electronics	37.11B
WuXi AppTec	37.92B
Aier Eye Hospital Group	20.62B
Zhangzhou Pientzehuang Pharmaceutical.,	10.91B
Shanghai United Imaging Healthcare	10.30B
Yunnan Baiyao Group Co.,Ltd	40.03B
Sichuan Biokin Pharmaceutical	5.82B

Revenue Rankings